Ó£»¨ÊÓƵ

Skip to main content

Table 1 Cohort description and clinical response categorization

From: A retrospective chart review and thematic analysis of patients seeking mpox vaccination during the initial outbreak in 2022–2023: evaluation of access, motivations, and stigma

Mean Age

48.6 ( range 17–78)

Sex listed on healthcard

 Male

97.3%

 Female

2.7%

Self-identified engagement

 Men who have sex with men

33.6%

 Transwoman

0.9%

 Sex work

1.8%

Travelled to receive vaccine

 From out of province

0.9%

 From out of country

0.9%

Mpox-related questions

 Prior smallpox vaccination

12.4%

 Would ask partners about mpox vaccination

51.3%

 Asymptomatic

100%

 Previous mpox infection

0.9%

 Previous sexual partner reported subsequent mpox infection

2.7%

 Pre-exposure vaccination

99.1%

 Post-exposure vaccination

0.9%

Vaccine eligibility

 Sex as the primary risk factor

(self-perceived high-risk, low-risk, no risk)

64.6%

(6.2%, 9.7%, 8.8%)

 Vaccine eligibility appropriate

39.8%

 Vaccines should be available to the general public

16.8%